An established New Jersey-based executive in the biopharmaceutical sphere, Loretta Itri, MD, has facilitated the development of multiple cancer drugs. An avid theatergoer, Dr. Loretta Itri recently took in a unique Broadway production of King Lear starring English actress Glenda Jackson. Having earned two Oscars across a storied acting career, Ms. Jackson held an elected seat in Parliament before being enticed back into acting on the London stage in 2016 at age 80. Despite an absence of two decades from thespian activities, she earned plaudits for her take on Shakespeare’s tragic king in an Old Vic performance directed by Deborah Warner. Instead of crossing the Atlantic with the production as expected, Ms. Jackson next earned a Tony Award for Best Actress in a Play for her portrayal of an “angry old woman” in Three Tall Women by Edward Albee. The King Lear production currently running on Broadway has a new supporting cast and features the often-subversive vision of director Sam Gold, who previously cast Daniel Craig in Othello.
0 Comments
Leave a Reply. |
AuthorAs chief medical officer and president of pharmaceutical development at a public biotech company, Dr. Loretta Itri oversaw the worldwide development of a number of important drugs, including Tesetaxel, a novel oral taxane used in the treatment of breast, gastric, and prostate cancer. Archives
October 2019
Categories |